153 related articles for article (PubMed ID: 16324314)
1. [Protection of gastric mucosa against steroids-induced damage by teprenone].
Lü B; Zhang L; Fan YH; Meng LN; Zhang S
Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2749-53. PubMed ID: 16324314
[TBL] [Abstract][Full Text] [Related]
2. [Effects of teprenone on expression of heat shock protein 70 and c-fos in stomach following prednisolone ingestion: experiment with rats].
Lü B; Zhang L; Fan YH; Xu Y
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):220-4. PubMed ID: 18361829
[TBL] [Abstract][Full Text] [Related]
3. [Preventive effects of teprenone on gastric mucosal lesions induced by Helicobacter pylori in mice].
Yang GB; Hu FL; Mu FH
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):992-5. PubMed ID: 16759543
[TBL] [Abstract][Full Text] [Related]
4. Increase in hepatic tissue blood flow by teprenone.
Kurihara T; Kitamura Y; Adachi Y; Obuchi M; Abe K; Akimoto M; Hashimoto H; Ishiguro H; Niimi A; Maeda A; Shigemoto M; Yamashita K; Yokoyama I
J Gastroenterol Hepatol; 1996 Oct; 11(10):978-84. PubMed ID: 8912138
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of geranylgeranylacetone on rat ethanol-induced gastritis.
Ning JW; Lin GB; Ji F; Xu J; Sharify N
World J Gastroenterol; 2012 May; 18(18):2262-9. PubMed ID: 22611321
[TBL] [Abstract][Full Text] [Related]
6. Preventive effect of teprenone on acute gastric mucosal lesion progression in compound 48/80-treated rats.
Ohta Y; Kobayashi T; Inui K; Yoshino J; Kitagawa A; Nakazawa S
Eur J Pharmacol; 2004 Mar; 487(1-3):223-32. PubMed ID: 15033395
[TBL] [Abstract][Full Text] [Related]
7. Teprenone, but not H2-receptor blocker or sucralfate, suppresses corpus Helicobacter pylori colonization and gastritis in humans: teprenone inhibition of H. pylori-induced interleukin-8 in MKN28 gastric epithelial cell lines.
Miyake K; Tsukui T; Shinji Y; Shinoki K; Hiratsuka T; Nishigaki H; Futagami S; Wada K; Gudis K; Iwakiri K; Yamada N; Sakamoto C
Helicobacter; 2004 Apr; 9(2):130-7. PubMed ID: 15068414
[TBL] [Abstract][Full Text] [Related]
8. Effects of the new anti-ulcer agent KB-5492 on experimental gastric mucosal lesions and gastric mucosal defensive factors, as compared to those of teprenone and cimetidine.
Morimoto Y; Shimohara K; Oshima S; Sukamoto T
Jpn J Pharmacol; 1991 Dec; 57(4):495-505. PubMed ID: 1803065
[TBL] [Abstract][Full Text] [Related]
9. Effects of anti-ulcer agents on ethanol-induced gastric mucosal lesions in D-galactosamine-induced hepatitis rats.
Taniguchi H; Yomota E; Nogi K; Onoda Y
Arzneimittelforschung; 2002; 52(8):600-4. PubMed ID: 12236047
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of teprenone against acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
Ohta Y; Kobayashi T; Inui K; Yoshino J; Nakazawa S
J Pharmacol Sci; 2003 Nov; 93(3):337-46. PubMed ID: 14646252
[TBL] [Abstract][Full Text] [Related]
11. [Non-steroidal anti-inflammatory drug induced gastropathy and preventive effects of teprenone on the gastropathy in rats].
Ma J; Yuan G; Chen MH
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2868-73. PubMed ID: 17200026
[TBL] [Abstract][Full Text] [Related]
12. Effect of teprenone on acute gastric mucosal lesions induced by cold-restraint stress.
Kunisaki C; Sugiyama M
Digestion; 1992; 53(1-2):45-53. PubMed ID: 1289172
[TBL] [Abstract][Full Text] [Related]
13. Teprenone promotes the healing of acetic acid-induced chronic gastric ulcers in rats by inhibiting neutrophil infiltration and lipid peroxidation in ulcerated gastric tissues.
Kobayashi T; Ohta Y; Yoshino J; Nakazawa S
Pharmacol Res; 2001 Jan; 43(1):23-30. PubMed ID: 11207062
[TBL] [Abstract][Full Text] [Related]
14. Teprenone for the prevention of low-dose aspirin-induced gastric mucosal injury in
Chitapanarux T; Lertprasertsuke N; Kongnak A
Scand J Gastroenterol; 2019 Oct; 54(10):1199-1204. PubMed ID: 31591940
[No Abstract] [Full Text] [Related]
15. Effect of teprenone on gastric mucosal injury induced by Helicobacter pylori in rats.
Saita H; Murakami M
Arzneimittelforschung; 2000 Dec; 50(12):1110-4. PubMed ID: 11190777
[TBL] [Abstract][Full Text] [Related]
16. Preventive effect of teprenone on stress-induced gastric mucosal lesions and its relation to gastric mucosal constitutive nitric oxide synthase activity.
Nishida K; Ohta Y; Ishiguro I
Pharmacol Res; 1999 Apr; 39(4):325-32. PubMed ID: 10208764
[TBL] [Abstract][Full Text] [Related]
17. Effect of teprenone on portal hypertensive gastric mucosa.
Tanoue K; Tarnawski AS; Kishihara F; Ohta M; Hashizume M; Sugimachi K; Sarfeh IJ
Digestion; 1996; 57(1):35-40. PubMed ID: 8626046
[TBL] [Abstract][Full Text] [Related]
18. Effect of gefarnate on acute gastric mucosal lesion progression in rats treated with compound 48/80, a mast cell degranulator, in comparison with that of teprenone.
Ohta Y; Kobayashi T; Imai Y; Inui K; Yoshino J; Nakazawa S
Biol Pharm Bull; 2005 Aug; 28(8):1424-30. PubMed ID: 16079487
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of teprenone on blood flow and incidence of histologic lesions in rat gastric mucosa after hemorrhage and retransfusion.
Hachiya A; Bessho M; Iwasaki T; Iida K; Otsuka S
Scand J Gastroenterol; 1996 Apr; 31(4):326-33. PubMed ID: 8726298
[TBL] [Abstract][Full Text] [Related]
20. Teprenone improves gastric mucosal injury and dyspeptic symptoms in long-term nonsteroidal anti-inflammatory drug users.
Gong Y; Huang X; Chen M; Xiong L
J Gastroenterol Hepatol; 2019 Aug; 34(8):1344-1350. PubMed ID: 30681185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
